Clinical Trial Update: Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating iCaritin soft capsule in combination with lenvatinib and TACE for hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Icaritin Soft Capsule (icaritin)
• Lenvatinib (lenvatinib)
• TACE

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN